{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:00:29Z","timestamp":1790913629638,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["#K08 CA270385"],"award-info":[{"award-number":["#K08 CA270385"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Adrenal incidentalomas are adrenal masses \u2265\u20091\u00a0cm discovered on imaging studies for unrelated clinical conditions. The prevalence of adrenal incidentalomas has increased as a byproduct of the widespread use of cross-sectional imaging, particularly in older adults. The clinical significance of adrenal incidentalomas varies based on tumor size, hormonal activity, and imaging characteristics. While most adrenal incidentalomas are benign and asymptomatic, a significant minority are hormonally active or malignant, necessitating careful evaluation and management. Adrenal hormone secretion can have significant clinical implications. Biochemical testing is crucial to assess for hormone excess, including steroid hormones (mineralocorticoids, glucocorticoids, and androgens), which are made in the adrenal cortex, as well as catecholamines, which are made in the adrenal medulla. Non-contrast computed tomography (CT) is the preferred modality for evaluating adrenal nodules as it allows for assessment of tissue density in Hounsfield units (HU). Benign lesions typically have an homogeneous appearance with HU \u2264\u200910. Contrast-enhanced CT with delayed washout can help differentiate benign tumors from malignant tumors. Tumors \u2265\u20094\u00a0cm, or those with indeterminate features may require further imaging, such as magnetic resonance imaging (MRI) or positron emission tomography (PET)\/CT. The management of adrenal incidentalomas is determined by hormonal secretion and imaging characteristics. Surgical resection is recommended for functional tumors and those that are suspicious for malignancy, including tumors \u2265\u20094\u00a0cm in size and those with rapid growth. Non-functional tumors &lt;\u20094 cm may undergo imaging surveillance. The goal of this review is to summarize the contemporary literature and guidelines on adrenal incidentalomas, and to describe the key principles regarding evaluation and management.<\/jats:p>","DOI":"10.1245\/s10434-025-17296-8","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:22:10Z","timestamp":1746192130000},"page":"4712-4719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Landmark Series: Evaluation and Management of Adrenal Incidentalomas"],"prefix":"10.1245","volume":"32","author":[{"given":"Lily","family":"Owei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-3638","authenticated-orcid":false,"given":"Heather","family":"Wachtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"1","key":"17296_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-8529(05)70122-5","volume":"29","author":"W Young Jr","year":"2000","unstructured":"Young W Jr. Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinol Metab Clin North Am. 2000;29(1):159\u201385.","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"4","key":"17296_CR2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF03344099","volume":"29","author":"SCA Bovio","year":"2006","unstructured":"Bovio SCA, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Inves. 2006;29(4):298\u2013302.","journal-title":"J Endocrinol Inves."},{"issue":"5","key":"17296_CR3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","volume":"190","author":"JH Song","year":"2008","unstructured":"Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008;190(5):1163\u20138.","journal-title":"AJR Am J Roentgenol."},{"issue":"11","key":"17296_CR4","first-page":"1361","volume":"81","author":"JMFI Willatt","year":"2010","unstructured":"Willatt JMFI. Radiologic evaluation of incidentally discovered adrenal masses. Am Fam Physician. 2010;81(11):1361\u20136.","journal-title":"Am Fam Physician."},{"issue":"1065","key":"17296_CR5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/postgradmedj-2013-132386","volume":"90","author":"E Davenport","year":"2014","unstructured":"Davenport E, Lang Ping Nam P, Wilson M, Reid A, Aspinall S. Adrenal incidentalomas: management in British district general hospitals. Postgrad Med J. 2014;90(1065):365\u20139.","journal-title":"Postgrad Med J."},{"issue":"4","key":"17296_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","volume":"149","author":"LSN Barzon","year":"2003","unstructured":"Barzon LSN, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149(4):273\u201385.","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"17296_CR7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","volume":"41","author":"MSA Sherlock","year":"2020","unstructured":"Sherlock MSA, Abbas A, Fraser S, Limumpornpetch P, Dineen R, Stewart PM. Adrenal incidentaloma. Endocr Rev. 2020;41(6):775\u2013820.","journal-title":"Endocr Rev."},{"issue":"6","key":"17296_CR8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","volume":"164","author":"M Terzolo","year":"2011","unstructured":"Terzolo M, Stigliano A, Chiodini I, et al. AME position statement on adrenal incidentaloma. Eur J Endocrinol. 2011;164(6):851\u201370.","journal-title":"Eur J Endocrinol."},{"issue":"11","key":"17296_CR9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","volume":"8","author":"A Ebbehoj","year":"2020","unstructured":"Ebbehoj A, Li D, Kaur RJ, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(11):894\u2013902.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"17296_CR10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.7326\/M22-1619","volume":"175","author":"Y Jing","year":"2022","unstructured":"Jing Y, Hu J, Luo R, et al. Prevalence and characteristics of adrenal tumors in an unselected screening population: a cross-sectional study. Ann Intern Med. 2022;175(10):1383\u201391.","journal-title":"Ann Intern Med."},{"issue":"6","key":"17296_CR11","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1377\/hlthaff.27.6.1491","volume":"27","author":"RMD Smith-Bindman","year":"2008","unstructured":"Smith-Bindman RMD, Larson EB. Rising use of diagnostic medical imaging in a large integrated health system. Health Affairs. 2008;27(6):1491\u2013502.","journal-title":"Health Affairs."},{"issue":"10","key":"17296_CR12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jacr.2010.06.013","volume":"7","author":"LL Berland","year":"2010","unstructured":"Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, Brink JA, Baker ME, Federle MP, Foley WD, Francis IR. Managing incidental findings on abdominal CT: white paper of the acr incidental findings committee. J Am Coll Radiol. 2010;7(10):754\u201373.","journal-title":"J Am Coll Radiol."},{"issue":"2","key":"17296_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","volume":"25","author":"G Mansmann","year":"2004","unstructured":"Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004;25(2):309\u201340.","journal-title":"Endocr Rev."},{"issue":"5","key":"17296_CR14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3904\/kjim.2013.28.5.557","volume":"28","author":"YY Cho","year":"2013","unstructured":"Cho YY, Suh S, Joung JY, et al. Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas. Korean J Intern Med. 2013;28(5):557\u201364.","journal-title":"Korean J Intern Med."},{"issue":"1","key":"17296_CR15","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023;189(1):G1\u201342.","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"17296_CR16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526\u201340.","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"17296_CR17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/bjs.9742","volume":"102","author":"M Iacobone","year":"2015","unstructured":"Iacobone M, Citton M, Scarpa M, Viel G, Boscaro M, Nitti D. Systematic review of surgical treatment of subclinical Cushing\u2019s syndrome. Br J Surg. 2015;102(4):318\u201330.","journal-title":"Br J Surg."},{"issue":"10","key":"17296_CR18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","volume":"157","author":"L Yip","year":"2022","unstructured":"Yip L, Duh QY, Wachtel H, et al. American association of endocrine surgeons guidelines for adrenalectomy: executive summary. JAMA Surg. 2022;157(10):870\u20137.","journal-title":"JAMA Surg."},{"issue":"16","key":"17296_CR19","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMcp2031112","volume":"384","author":"E Kebebew","year":"2021","unstructured":"Kebebew E. Adrenal incidentaloma. N Engl J Med. 2021;384(16):1542\u201351.","journal-title":"N Engl J Med."},{"issue":"6","key":"17296_CR20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-07-0424","volume":"157","author":"S Kidambi","year":"2007","unstructured":"Kidambi S, Raff H, Findling JW. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing\u2019s syndrome. Eur J Endocrinol. 2007;157(6):725\u201331.","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"17296_CR21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/EJE-08-0485","volume":"160","author":"B Masserini","year":"2009","unstructured":"Masserini B, Morelli V, Bergamaschi S, et al. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol. 2009;160(1):87\u201392.","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"17296_CR22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1245\/s10434-014-3933-x","volume":"22","author":"H Wachtel","year":"2015","unstructured":"Wachtel H, Cerullo I, Bartlett EK, et al. Clinicopathologic characteristics of incidentally identified pheochromocytoma. Ann Surg Oncol. 2015;22(1):132\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"17296_CR23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"17296_CR24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"Brown JM, Siddiqui M, Calhoun DA, et al. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med. 2020;173(1):10\u201320.","journal-title":"Ann Intern Med."},{"issue":"1","key":"17296_CR25","first-page":"1","volume":"15","author":"MA Zeiger","year":"2009","unstructured":"Zeiger MA, Thompson GB, Duh QY, et al. The American association of clinical endocrinologists and american association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract Jul-Aug. 2009;15(1):1\u201320.","journal-title":"Endocr Pract. Jul-Aug"},{"issue":"12","key":"17296_CR26","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","volume":"96","author":"W Arlt","year":"2011","unstructured":"Arlt W, Biehl M, Taylor AE, et al. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab. 2011;96(12):3775\u201384.","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"17296_CR27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","volume":"8","author":"I Bancos","year":"2020","unstructured":"Bancos I, Taylor AE, Chortis V, et al. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. Lancet Diabetes Endocrinol. 2020;8(9):773\u201381.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"17296_CR28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0720-048X(01)00444-2","volume":"41","author":"MESJ Lockhart","year":"2002","unstructured":"Lockhart MESJ, Kenney PJ. Imaging of adrenal masses. Eur J Radiol. 2002;41(2):95\u2013112.","journal-title":"Eur J Radiol."},{"issue":"4","key":"17296_CR29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00261-010-9647-z","volume":"36","author":"GW Boland","year":"2011","unstructured":"Boland GW. Adrenal imaging. Abdom Imaging. 2011;36(4):472\u201382.","journal-title":"Abdom Imaging."},{"issue":"1","key":"17296_CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3803\/EnM.2020.35.1.26","volume":"35","author":"G Reimondo","year":"2020","unstructured":"Reimondo G, Muller A, Ingargiola E, Puglisi S, Terzolo M. Is follow-up of adrenal incidentalomas always mandatory? Endocrinol Metab (Seoul). 2020;35(1):26\u201335.","journal-title":"Endocrinol Metab (Seoul)."},{"issue":"2","key":"17296_CR31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5152\/tud.2023.22245","volume":"49","author":"BS Jackson","year":"2023","unstructured":"Jackson BS. Adrenal incidentaloma controversial size recommendations. Urol Res Pract. 2023;49(2):96\u20139.","journal-title":"Urol Res Pract."},{"issue":"2","key":"17296_CR32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3803\/EnM.2017.32.2.200","volume":"32","author":"JM Lee","year":"2017","unstructured":"Lee JM, Kim MK, Ko SH, et al. Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab (Seoul). 2017;32(2):200\u201318.","journal-title":"Endocrinol Metab (Seoul)."},{"issue":"2","key":"17296_CR33","first-page":"637","volume":"85","author":"FTM Mantero","year":"2000","unstructured":"Mantero FTM, Arnaldi G, Osella G, Masini AM, Al\u00ec A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab. 2000;85(2):637\u201344.","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"17296_CR34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.crad.2014.06.020","volume":"69","author":"N Schieda","year":"2014","unstructured":"Schieda N, Al Dandan O, Kielar AZ, Flood TA, McInnes MD, Siegelman ES. Pitfalls of adrenal imaging with chemical shift MRI. Clin Radiol. 2014;69(11):1186\u201397.","journal-title":"Clin Radiol."},{"issue":"4","key":"17296_CR35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.rcl.2014.02.003","volume":"52","author":"AH Davarpanah","year":"2014","unstructured":"Davarpanah AH, Israel GM. MR imaging of the kidneys and adrenal glands. Radiol Clin North Am. 2014;52(4):779\u201398.","journal-title":"Radiol Clin North Am."},{"issue":"3","key":"17296_CR36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ecl.2017.04.009","volume":"46","author":"M Mendiratta-Lala","year":"2017","unstructured":"Mendiratta-Lala M, Avram A, Turcu AF, Dunnick NR. Adrenal imaging. Endocrinol Metab Clin North Am. 2017;46(3):741\u201359.","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"4","key":"17296_CR37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2214\/AJR.08.1431","volume":"192","author":"GW Boland","year":"2009","unstructured":"Boland GW, Blake MA, Holalkere NS, Hahn PF. PET\/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol. 2009;192(4):956\u201362.","journal-title":"AJR Am J Roentgenol."},{"issue":"4","key":"17296_CR38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","volume":"50","author":"L Fishbein","year":"2021","unstructured":"Fishbein L, Del Rivero J, Else T, et al. The North American neuroendocrine tumor society consensus guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma. Pancreas. 2021;50(4):469\u201393.","journal-title":"Pancreas."},{"issue":"17","key":"17296_CR39","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","volume":"21","author":"I Janssen","year":"2015","unstructured":"Janssen I, Blanchet EM, Adams K, et al. Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma. Clin Cancer Res. 2015;21(17):3888\u201395.","journal-title":"Clin Cancer Res."},{"issue":"10","key":"17296_CR40","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","volume":"43","author":"I Janssen","year":"2016","unstructured":"Janssen I, Chen CC, Millo CM, et al. PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2016;43(10):1784\u201391.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"2","key":"17296_CR41","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/EJE-16-0297","volume":"175","author":"I Bancos","year":"2016","unstructured":"Bancos I, Tamhane S, Shah M, et al. Diagnosis of endocrine disease: the diagnostic performance of adrenal biopsy: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175(2):R65-80.","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"17296_CR42","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archsurg.2009.59","volume":"144","author":"P Mazzaglia","year":"2009","unstructured":"Mazzaglia P, Monchik JM. Limited value of adrenal biopsy in the evaluation of adrenal neoplasm: a decade of experience. Arch Surg. 2009;144(5):465\u201370.","journal-title":"Arch Surg."},{"issue":"6","key":"17296_CR43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-17-0372","volume":"177","author":"AR Hong","year":"2017","unstructured":"Hong AR, Kim JH, Park KS, et al. Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice. Eur J Endocrinol. 2017;177(6):475\u201383.","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"17296_CR44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","volume":"171","author":"YS Elhassan","year":"2019","unstructured":"Elhassan YS, Alahdab F, Prete A, et al. Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis. Ann Intern Med. 2019;171(2):107\u201316.","journal-title":"Ann Intern Med."},{"issue":"4","key":"17296_CR45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3803\/EnM.2023.1779","volume":"38","author":"SS Park","year":"2023","unstructured":"Park SS, Kim JH. Recent updates on the management of adrenal incidentalomas. Endocrinol Metab (Seoul). 2023;38(4):373\u201380.","journal-title":"Endocrinol Metab (Seoul)."},{"issue":"8","key":"17296_CR46","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.7326\/M20-7946","volume":"174","author":"A Kjellbom","year":"2021","unstructured":"Kjellbom A, Lindgren O, Puvaneswaralingam S, Londahl M, Olsen H. Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas\u202f: a cohort study. Ann Intern Med. 2021;174(8):1041\u20139.","journal-title":"Ann Intern Med."},{"issue":"7","key":"17296_CR47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","volume":"10","author":"T Deutschbein","year":"2022","unstructured":"Deutschbein T, Reimondo G, Di Dalmazi G, et al. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol. 2022;10(7):499\u2013508.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"17296_CR48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jss.2021.07.041","volume":"269","author":"T Feeney","year":"2022","unstructured":"Feeney T, Madiedo A, Knapp PE, Gupta A, McAneny D, Drake FT. Incidental adrenal masses: adherence to guidelines and methods to improve initial follow-up: a systematic review. J Surg Res. 2022;269:18\u201327.","journal-title":"J Surg Res."},{"issue":"5","key":"17296_CR49","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.surg.2019.07.034","volume":"167","author":"T Feeney","year":"2020","unstructured":"Feeney T, Talutis S, Janeway M, et al. Evaluation of incidental adrenal masses at a tertiary referral and trauma center. Surgery. 2020;167(5):868\u201375.","journal-title":"Surgery."},{"issue":"1","key":"17296_CR50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jacr.2022.11.011","volume":"20","author":"AP Woods","year":"2023","unstructured":"Woods AP, Ft Godley, Feeney T, et al. A Standardized radiology template improves incidental adrenal mass follow-up: a prospective effectiveness and implementation study. J Am Coll Radiol. 2023;20(1):87\u201397.","journal-title":"J Am Coll Radiol."},{"issue":"5","key":"17296_CR51","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/XCS.0000000000000930","volume":"238","author":"AP Woods","year":"2024","unstructured":"Woods AP, Feeney T, Gupta A, Knapp PE, McAneny D, Drake FT. Prospective study of a system-wide adrenal incidentaloma quality improvement initiative. J Am Coll Surg. 2024;238(5):961\u201370.","journal-title":"J Am Coll Surg."},{"issue":"12","key":"17296_CR52","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/wjs.12346","volume":"48","author":"CC Frye","year":"2024","unstructured":"Frye CC, Akhund R, Murcy M, et al. A natural language processing-informed adrenal gland incidentaloma clinic improves guideline-based care. World J Surg. 2024;48(12):2907\u201317.","journal-title":"World J Surg."},{"issue":"1","key":"17296_CR53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/XCS.0000000000001221","volume":"240","author":"JE Passman","year":"2025","unstructured":"Passman JE, Hwang J, Tang J, et al. Active choice nudge to increase screening for primary aldosteronism in at-risk patients. J Am Coll Surg. 2025;240(1):46\u201359.","journal-title":"J Am Coll Surg."},{"issue":"11","key":"17296_CR54","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","volume":"106","author":"I Bancos","year":"2021","unstructured":"Bancos I, Prete A. Approach to the patient with adrenal incidentaloma. J Clin Endocrinol Metab. 2021;106(11):3331\u201353.","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"17296_CR55","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1210\/clinem\/dgad044","volume":"108","author":"E Sconfienza","year":"2023","unstructured":"Sconfienza E, Tetti M, Forestiero V, Veglio F, Mulatero P, Monticone S. Prevalence of functioning adrenal incidentalomas: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2023;108(7):1813\u201323.","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"17296_CR56","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1210\/jc.2011-0085","volume":"96","author":"MA Zeiger","year":"2011","unstructured":"Zeiger MA, Siegelman SS, Hamrahian AH. Medical and surgical evaluation and treatment of adrenal incidentalomas. J Clin Endocrinol Metab. 2011;96(7):2004\u201315.","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17296-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:58:21Z","timestamp":1748869101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17296-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["17296"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17296-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lily Owei and Heather Wachtel have no conflicts of interest to declare that may be relevant to the contents of this review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}